INDEMNIFICATION AGREEMENTIndemnification Agreement • August 9th, 2017 • Novus Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of , 2017 by and between Novus Therapeutics, Inc., a Delaware corporation (the “Company”), and (the “Indemnitee”). This Agreement supersedes and replaces any and all previous Agreements between the Company (or any predecessor or subsidiary of the Company) and Indemnitee covering the subject matter of this Agreement.
LEASE BETWEEN THE IRVINE COMPANY LLC AND OTIC PHARMA, INC.Lease • August 9th, 2017 • Novus Therapeutics, Inc. • Pharmaceutical preparations • California
THIS LEASE is made as of September 2, 2015, by and between THE IRVINE COMPANY LLC, a Delaware limited liability company, hereafter called “Landlord,” and OTIC PHARMA, INC., a Delaware corporation, hereafter called “Tenant.”
NOVUS THERAPEUTICS, INC. MANAGEMENT CONTINUITY AGREEMENTManagement Continuity Agreement • August 9th, 2017 • Novus Therapeutics, Inc. • Pharmaceutical preparations • California
This Management Continuity Agreement (the “Agreement”) is effective as of August 7, 2017 (the “Effective Date”) by and between Gregory J. Flesher (“Employee”) and Novus Therapeutics. Inc, a Delaware corporation (the “Company”). This Agreement is intended to provide Employee with certain benefits described herein upon the occurrence of specific events.
Pursuant to 17 CFR 20.24b-2, confidential information has been omitted in places marked “***” and has been filed separately with the Securities and Exchange Commission pursuant to a Confidential Treatment Request with the Commission. EXCLUSIVE LICENSE...Exclusive License Agreement • August 9th, 2017 • Novus Therapeutics, Inc. • Pharmaceutical preparations • New York
This Exclusive License Agreement (“Agreement”) dated November 1, 2015 (“Effective Date”), is between Scientific Development and Research, Inc., a New Jersey corporation having offices located at 55 Alexandria Road, Morristown, NJ 07960 (“SDRI”) and Otodyne, Inc., a Delaware corporation also having offices located at 55 Alexandria Road, Morristown, NJ 07960 (“Otodyne,” together with SDRI, the “Licensors” and each, a “Licensor”), on one hand, and OticPharma, Inc., a Delaware corporation having offices at 19900 MacArthur Blvd, Suite 550, Irvine, CA 92612 (“OPI”), on the other hand. Each of SDRI, Otodyne and OPI may be referred to hereinafter individually as a “Party” and together as the “Parties.”
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 9th, 2017 • Novus Therapeutics, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”), dated July 15, 2015, is between Otic Pharma, Inc., a Delaware corporation in formation (the “Company”), and Gregory J. Flesher, an individual (the “Executive”).
